参考文献/References:
[1] 杜向一,闫长祥.内源性大麻素系统与神经胶质瘤细胞增殖与凋亡的关系分析[J].陕西医学杂志,2014,43(4):387-389.
[2] Cristino L,Bisogno T,Di Marzo V.Cannabinoids and the expanded endocannabinoid system in neurological disorders[J].Nature Reviews Neurology,2020,16(1):9-29.
[3] 刘 娟,田 磊,赵 杨,等.电针对慢性应激抑郁模型大鼠脑组织内大麻素水解酶的影响[J].陕西中医,2019,40(5):553-555.
[4] Aymerich MS,Aso E,Abellanas MA,et al.Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system[J].Biochemical Pharmacology,2018,157:67-84.
[5] 杨嘉颖,赵胤安,宋 欣,等.氯硝柳胺抑制小胶质细胞炎症作用研究[J].陕西医学杂志,2018,47(3):275-278.
[6] Al-Mamun A,Chauhan A,Qi S,et al.Microglial IRF5-IRF4 regulatory axis regulates neuroinflammation after cerebral ischemia and impacts stroke outcomes[J].Proceedings of the National Academy of Sciences of the United States of America,2020,117(3):1742-1752.
[7] Yang Q,Zhou J.Neuroinflammation in the central nervous system:Symphony of glial cells [J].Glia,2019,67(6):1017-1035.
[8] Iovino L,Tremblay ME,Civiero L.Glutamate-induced excitotoxicity in Parkinson's disease:The role of glial cells [J].Journal of Pharmacological Sciences,2020,144(3):151-164.
[9] Scheefhals N,Mac-Gillavry HD.Functional organization of postsynaptic glutamate receptors[J].Molecular and Cellular Neurosciences,2018,91:82-94.
[10] Iovino L,Tremblay ME,Civiero L.Glutamate-induced excitotoxicity in Parkinson's disease:The role of glial cells[J].Journal of Pharmacological Sciences,2020,144(3):151-164.
[11] Binvignat O,Olloquequi J.Excitotoxicity as a target against neurodegenerative processes[J].Current Pharma-ceutical Design,2020,26(12):1251-1262.
[12] Pál B.Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability [J].Cellular and Molecular Life Sciences:CMLS,2018,75(16):2917-2949.
[13] Maher P,Van-Leyen K,Dey PN,et al.The role of Ca2+ in cell death caused by oxidative glutamate toxicity[J].Cell Calcium,2018,70:47-55.
[14] 张霞婧,贾 济,陈希瑶,等.大麻素受体2在谷氨酸诱发小胶质细胞损伤中的作用[J].中华麻醉学杂志,2012,32(6):739-741.
[15] Allen NJ,Lyons DA.Glia as architects of central nervous system formation and function [J].Science,2018,362(6411):181-185.
[16] Kelly R,Joers V,Tansey MG,et al.Microglial phenotypes and their relationship to the cannabinoid system:Therapeutic implications for parkinson's disease [J].Molecules,2020,25(3):157-163.
[17] Marinelli S,Basilico B,Marrone MC,et al.Microglia-neuron crosstalk:Signaling mechanism and control of synaptic transmission [J].Seminars in Cell & Developmental Biology,2019,94:138-151.
[18] Cakir M,Tekin S,Doganyigit Z,et al.Cannabinoid type 2 receptor agonist JWH-133,attenuates okadaic acid induced spatial memory impairment and neurodegeneration in rats[J].Life Sciences,2019,217:25-33.
[19] Javed H,Azimullah S,Haque ME,et al.Cannabinoid type 2(CB2)receptors activation protects against oxidative stress and neuroinflammation associated dopaminergic neurodegeneration in rotenone model of parkinson's disease[J].Frontiers in Neuroscience,2016,10:321.
[20] Alcigir ME,Dogan HO,Atalay-Vural S,et al.Neuroprotective activity of cannabinoid receptor-2 against oxidative stress and apoptosis in rat pups having experimentally-induced congenital hypothyroidism [J].Developmental Neurobiology,2017,77(11):1334-1347.